Lipocine (STU:2VT0) Float Percentage Of Total Shares Outstanding: 98.13% (As of Jul. 02, 2026)


STU:2VT0 Lipocine Inc STU:2VT0
50 GF Score
Price €3.94
GF Value €2.90
! 4 Warning Signs
View Full Analysis

What is Lipocine Float Percentage Of Total Shares Outstanding?

Lipocine STU:2VT0 50 Float Percentage Of Total Shares Outstanding is 98.13% as of Jul. 02, 2026. GuruFocus rates STU:2VT0 with a GF Score™ of 50/100 and a GF Value™ of €2.90. The stock has 4 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Lipocine's float shares is 8.09 Mil. Lipocine's total shares outstanding is 8.24 Mil. Lipocine's float percentage of total shares outstanding is 98.13%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Lipocine's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Lipocine's Institutional Ownership is 5.58%.

STU:2VT0
50GF Score
Lipocine Inc STU:2VT0
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lipocine Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Lipocine's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=8.09/8.24
=98.13%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 98.13% mean?
Lipocine (STU:2VT0) has a Float Percentage Of Total Shares Outstanding of 98.13% as of Jul. 02, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Lipocine and its competitors.
Is Lipocine's Float Percentage Of Total Shares Outstanding too high?
Lipocine's current Float Percentage Of Total Shares Outstanding is 98.13%. Overall, Lipocine has a GF Score™ of 50/100, reflecting its overall financial health beyond just this single metric.
How does Lipocine's Float Percentage Of Total Shares Outstanding compare to NCEL and PTN?
Lipocine's Float Percentage Of Total Shares Outstanding of 98.13% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Lipocine and its competitors. Lipocine's current Float Percentage Of Total Shares Outstanding is 98.13%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lipocine stock overvalued right now?
Lipocine (STU:2VT0) has a current Float Percentage Of Total Shares Outstanding of 98.13%. The stock's GF Value™ is €2.90, compared to a current price of €3.94 — trading 36% above its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 98.13%. Lipocine's overall GF Score™ is 50/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Lipocine (STU:2VT0), the current Float Percentage Of Total Shares Outstanding is 98.13% as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lipocine (STU:2VT0) Overvalued in 2026?

Based on GuruFocus' analysis, Lipocine stock appears to be overvalued. The current stock price of €3.94 is trading 36% above its estimated GF Value™ of €2.90.

Key valuation signals for STU:2VT0:

  • Float Percentage Of Total Shares Outstanding: 98.13%
  • GF Value™: €2.90 vs. price of €3.94 (36% above fair value)
  • GF Score™: 50/100 with 4 warning signs

No single metric tells the full story. See the STU:2VT0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lipocine Business Description

Other Exchanges LPCN:USA
Address 675 Arapeen Drive, Suite 202, Salt Lake City, UT, USA, 84108
Lipocine Inc is a clinical-stage biopharmaceutical company that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates, or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy (TRT). It also has other products in the pipeline, such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.
50GF Score

Get the complete analysis for STU:2VT0

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.94
Price
€2.90
GF Value